cbdMD, Inc. (YCBD)

ASE – Цена в реальном времени. Валюта: USD

0.70

-0.01 (-1.12%)

При закрытии: Jun 26, 2026, 3:59 PM EDT

0.70

+0.00 (0.70%)

После закрытия: Jun 26, 2026, 7:32 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

cbdMD, Inc. (YCBD)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

cbdMD, Inc. (YCBD)

cbdMD Appoints Wade Brown Chief Marketing Officer

cbdMD, Inc. (YCBD) Q2 2026 Earnings Call Transcript

cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum

cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results

cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare

cbdMD, Inc. (YCBD) Q1 2026 Earnings Call Transcript

cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

Видео

No Data

Пресс-релизы

cbdMD Appoints Wade Brown Chief Marketing Officer

cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum

cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare

cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

Search stocks

cbdMD, Inc. (YCBD)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

cbdMD, Inc. (YCBD)

cbdMD Appoints Wade Brown Chief Marketing Officer

cbdMD, Inc. (YCBD) Q2 2026 Earnings Call Transcript

cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum

cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results

cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare

cbdMD, Inc. (YCBD) Q1 2026 Earnings Call Transcript

cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

Видео

No Data

Пресс-релизы

cbdMD Appoints Wade Brown Chief Marketing Officer

cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum

cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare

cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026